Hyperion Defi, Inc.
HYPD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001682639
No open-market purchases or sales by Hyperion Defi, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $7.92M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Hyperion Defi, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 18 | 18 | 0 |
| Shares | 278.5K | 140.2K | −138.4K (−49.7%) |
| Value | $306.0K | $1.45M | +$1.15M (+375.4%) |
New holders (5)
Institutions that held Hyperion Defi, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Caitong International Asset Management Co., Ltd | 53,773 | $558.2K | 0.40% |
| Jane Street Group, LLC | 12,570 | $130.5K | 0.00% |
| XTX Topco Ltd | 11,298 | $117.3K | 0.00% |
| Allworth Financial LP | 3,500 | $36.3K | 0.00% |
| Citigroup Inc | 410 | $4.26K | 0.00% |
Sold out (5)
Institutions that held Hyperion Defi, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Lasry Marc | 30,618 | $33.7K |
| Citadel Advisors LLC | 12,259 | $13.5K |
| Barclays PLC | 520 | $572 |
| Advisor Group Holdings, Inc. | 275 | $302 |
| Tower Research Capital LLC (TRC) | 41 | $45 |